X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (67) 67
male (47) 47
index medicus (38) 38
middle aged (37) 37
female (33) 33
adult (27) 27
infectious diseases (23) 23
virology (22) 22
france (20) 20
infection (19) 19
aged (18) 18
gastroenterology & hepatology (18) 18
animals (16) 16
hepatitis e virus (15) 15
therapy (15) 15
genotype (14) 14
hepatitis e - virology (14) 14
hepatocellular carcinoma (13) 13
health aspects (12) 12
infectious disease (12) 12
life sciences (12) 12
microbiology (12) 12
human health and pathology (11) 11
oncology (11) 11
[sdv.mhep.mi]life sciences [q-bio]/human health and pathology/infectious diseases (10) 10
antiviral agents - therapeutic use (10) 10
cirrhosis (10) 10
france - epidemiology (10) 10
hepatitis e (10) 10
hepatitis e virus - genetics (10) 10
hepatitis e virus - isolation & purification (10) 10
aged, 80 and over (9) 9
hepatitis b virus - genetics (9) 9
hepatitis e - epidemiology (9) 9
liver (9) 9
treatment outcome (9) 9
cancer (8) 8
care and treatment (8) 8
hepatitis b (8) 8
hepatitis e - diagnosis (8) 8
hepatitis e virus - classification (8) 8
immunology (8) 8
prevalence (8) 8
transplantation (8) 8
diversity (7) 7
hepacivirus - genetics (7) 7
hepatitis (7) 7
pharmacology & pharmacy (7) 7
retrospective studies (7) 7
rna, viral - blood (7) 7
viruses (7) 7
[ sdv.mhep.mi ] life sciences [q-bio]/human health and pathology/infectious diseases (6) 6
hepatitis antibodies - blood (6) 6
hepatitis b virus (6) 6
hepatitis e - complications (6) 6
hepatitis e virus - immunology (6) 6
in-vivo (6) 6
kidney transplantation - adverse effects (6) 6
liver transplantation (6) 6
rats (6) 6
rna, viral - genetics (6) 6
transmission (6) 6
viral nonstructural proteins - genetics (6) 6
allergy and immunology (5) 5
biotechnology & applied microbiology (5) 5
blood-donors (5) 5
carcinoma, hepatocellular - pathology (5) 5
carcinoma, hepatocellular - therapy (5) 5
diagnosis (5) 5
disease (5) 5
drug therapy (5) 5
epidemiology (5) 5
expression (5) 5
gastroenterology and hepatology (5) 5
genetics & heredity (5) 5
hepatitis b antibodies - blood (5) 5
hepatitis c - drug therapy (5) 5
hepatitis e - drug therapy (5) 5
hepatoma (5) 5
immunoglobulin g - blood (5) 5
internal medicine (5) 5
liver cancer (5) 5
medicine, research & experimental (5) 5
mutation (5) 5
phylogeny (5) 5
sequence analysis, dna (5) 5
transduction, genetic (5) 5
young adult (5) 5
zoonosis (5) 5
acute disease (4) 4
acute hepatitis (4) 4
adolescent (4) 4
alanine transaminase - blood (4) 4
antibodies (4) 4
antigen (4) 4
carcinoma, hepatocellular - drug therapy (4) 4
carcinoma, hepatocellular - genetics (4) 4
carcinoma, hepatocellular - metabolism (4) 4
drug resistance, viral (4) 4
europe (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10064, pp. 56 - 66
Journal Article
by Vilgrain, Valérie and Pereira, Helena and Assenat, Eric and Guiu, Boris and Ilonca, Alina Diana and Ilonca, Alina D and Pageaux, Georges-Philippe and Sibert, Annie and Bouattour, Mohamed and Lebtahi, Rachida and Allaham, Wassim and Barraud, Hélène and Laurent, Valérie and Mathias, Elodie and Bronowicki, Jean-Pierre and Tasu, Jean-Pierre and Perdrisot, Rémy and Silvain, Christine and Gerolami, René and Mundler, Olivier and Seitz, Jean-Francois and Vidal, Vincent and Aubé, Christophe and Oberti, Frédéric and Couturier, Olivier and Brenot-Rossi, Isabelle and Raoul, Jean-Luc and Sarran, Anthony and Costentin, Charlotte and Itti, Emmanuel and Luciani, Alain and Adam, René and Lewin, Maïté and Samuel, Didier and Ronot, Maxime and Dinut, Aurelia and Castera, Laurent and Chatellier, Gilles and Delhom - Christol, Elisabeth and Lonjon, Julie and Abdel-Rehim, Mohamed and Dieudonné, Arnaud and Bazin, Christophe and Chagneau-Derrode, Carine and Borentain, Patrick and Bouvier, Antoine and Vervueren, Laurent and Chalaye, Julia and Kobeiter, Hicham and Edeline, Julien and Garin, Etienne and Rolland, Yan and Archambeaud, Isabelle and Eugene, Thomas and Frampas, Eric and Cassinotto, Christophe and Guyot, Martine and Hiriart, Jean-Baptiste and Lapuyade, Bruno and Vergniol, Julien and Bachellier, Philippe and Detour, Julien and Duclos, Bernard and Greget, Michel and Habersetzer, Francois and Imperiale, Alessio and Merle, Philippe and Rode, Agnès and Morvan, Julie and Nguyen-Khac, Eric and Yzet, Thierry and Baudin, Guillaume and Chevallier, Patrick and Mahamat, Abakar and Piche, Thierry and Razzouk, Micheline and Hillon, Patrick and Loffroy, Romaric and Toubeau, Michel and Vincent, Julie and Barabino, Gabriele and Bouarioua, Nadia and Cuilleron, Muriel and Ecochard, Marie and Prevot-Bitot, Nathalie and Leroy, Vincent and Roux, Julie and Sengel, Christian and Bourcier, Valérie and Ganne-Carrie, Nathalie and Seror, Olivier and Costo, Sylvie and Dao, Thông and Pelage, Jean-Pierre and Dumortier, Jérôme and Giammarile, Francesco and Valette, Pierre-Jean and Ghazzar, Nadia and Pellerin, Olivier and Taieb, Julien and ... and SARAH Trial Grp and SARAH Trial Group
The Lancet Oncology, ISSN 1470-2045, 12/2017, Volume 18, Issue 12, pp. 1624 - 1636
Sorafenib is the recommended treatment for patients with advanced hepatocellular carcinoma. We aimed to compare the efficacy and safety of sorafenib to that of... 
SURVIVAL | THERAPY | ONCOLOGY | COMPETING RISK | TRANSARTERIAL CHEMOEMBOLIZATION | RADIOEMBOLIZATION | QUALITY-OF-LIFE | Niacinamide - analogs & derivatives | Carcinoma, Hepatocellular - mortality | Follow-Up Studies | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Liver Neoplasms - mortality | Dose-Response Relationship, Drug | Microspheres | Carcinoma, Hepatocellular - drug therapy | Antineoplastic Agents - adverse effects | Neoplasm Invasiveness - pathology | Phenylurea Compounds - adverse effects | Adult | Female | Liver Neoplasms - pathology | Yttrium Radioisotopes - therapeutic use | Radiotherapy Dosage | Drug Administration Schedule | Administration, Oral | Brachytherapy - methods | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Niacinamide - adverse effects | Carcinoma, Hepatocellular - radiotherapy | Treatment Outcome | Niacinamide - administration & dosage | Disease-Free Survival | Phenylurea Compounds - administration & dosage | Liver Neoplasms - radiotherapy | Sorafenib | Carcinoma, Hepatocellular - pathology | Survival Analysis | Aged | Neoplasm Staging | Rare earth metals | Antimitotic agents | Product development | Hepatoma | Comparative analysis | Radiotherapy | Antineoplastic agents | Life Sciences | Liver Neoplasms/drug therapy | Phenylurea Compounds/administration & dosage | Yttrium Radioisotopes/therapeutic use | Niacinamide/analogs & derivatives | Carcinoma, Hepatocellular/radiotherapy | Carcinoma, Hepatocellular/drug therapy | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 02/2008, Volume 358, Issue 8, pp. 859 - 860
The authors report a rapidly progressing case of cirrhosis in a renal-transplant recipient with chronic hepatitis E virus infection. To the Editor: Hepatitis E... 
MEDICINE, GENERAL & INTERNAL | INFECTION | E-VIRUS | Hepatitis, Chronic | Liver Cirrhosis - virology | Humans | Middle Aged | Liver Cirrhosis - pathology | Male | Alanine Transaminase - blood | Hepatitis E - transmission | Hepatitis E - diagnosis | Hepatitis E virus | Kidney Transplantation - adverse effects
Journal Article
Journal of Medical Virology, ISSN 0146-6615, 03/2013, Volume 85, Issue 3, pp. 462 - 471
Journal Article
Journal of Hepatology, ISSN 0168-8278, 08/2018, Volume 69, Issue 2, pp. 353 - 358
The RESORCE trial showed that regorafenib improves overall survival (OS) in patients with hepatocellular carcinoma progressing during sorafenib treatment... 
Regorafenib | Survival analysis | Treatment outcome | Hepatocellular carcinoma | Sorafenib | ADVANCED HEPATOCELLULAR-CARCINOMA | SURVIVAL | MULTICENTER | PLACEBO | SAFETY | FAILURE | THERAPY | DOUBLE-BLIND | GASTROENTEROLOGY & HEPATOLOGY
Journal Article